Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

Dr. Wu Skincare Co., Ltd. (6523.TWO)

Compare
143.00
+12.50
+(9.58%)
As of 11:56:25 AM GMT+8. Market Open.
Loading Chart for 6523.TWO
  • Previous Close 130.50
  • Open 141.50
  • Bid 142.00 x --
  • Ask 143.00 x --
  • Day's Range 139.00 - 143.50
  • 52 Week Range 127.50 - 193.50
  • Volume 172,800
  • Avg. Volume 61,201
  • Market Cap (intraday) 6.442B
  • Beta (5Y Monthly) 0.28
  • PE Ratio (TTM) 13.57
  • EPS (TTM) 10.54
  • Earnings Date May 15, 2025 - May 19, 2025
  • Forward Dividend & Yield 11.00 (7.59%)
  • Ex-Dividend Date Mar 27, 2025
  • 1y Target Est --

Dr. Wu Skincare Co., Ltd. engages in the research, development, production, wholesale, and retail of cosmetics and skincare products in Taiwan and internationally. The company offers collagen peptide powders, cleansers, masks, toners, serums, hydrating lotions/creams/gels, UV/DD creams, and eye care products, as well as makeup and body products. It also provides products for acne and pores, blackheads, dry skin, signs of aging, dull and spotty skin, sensitive skin, whitening, and emergency care. The company was incorporated in 2003 and is based in Taipei, Taiwan.

www.drwu.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6523.TWO

View More

Performance Overview: 6523.TWO

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6523.TWO
3.37%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
17.54%

1-Year Return

6523.TWO
13.31%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
8.52%

3-Year Return

6523.TWO
95.65%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
9.90%

5-Year Return

6523.TWO
330.25%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
87.00%

Compare To: 6523.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6523.TWO

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    5.88B

  • Enterprise Value

    5.02B

  • Trailing P/E

    12.38

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.75

  • Price/Book (mrq)

    4.04

  • Enterprise Value/Revenue

    4.04

  • Enterprise Value/EBITDA

    8.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    38.35%

  • Return on Assets (ttm)

    18.67%

  • Return on Equity (ttm)

    32.52%

  • Revenue (ttm)

    1.24B

  • Net Income Avi to Common (ttm)

    476.25M

  • Diluted EPS (ttm)

    10.54

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    908.72M

  • Total Debt/Equity (mrq)

    3.21%

  • Levered Free Cash Flow (ttm)

    405.5M

Research Analysis: 6523.TWO

View More

Company Insights: 6523.TWO

Research Reports: 6523.TWO

View More

People Also Watch